Blue Jays' Davis Schneider Becomes Paid Narcan Spokesperson After Brother's Overdose Death
Schneider accepted a paid role to promote naloxone after his brother’s overdose death, as Canada records more than 55,000 opioid poisoning deaths since 2016.
- On Wednesday, Toronto Blue Jays player Davis Schneider became a paid spokesperson for Emergent BioSolutions, manufacturer of Narcan nasal spray, to raise awareness about opioid overdose prevention.
- Schneider's advocacy follows the November 2020 death of his 26-year-old brother, Steven, who died alone from an opioid overdose in a New Jersey home where naloxone could have saved his life.
- Emergency physician Dr. Taryn Lloyd notes denial often prevents people from carrying naloxone, which reverses respiratory failure from opioids; more than 55,000 Canadians have died in the crisis since 2016.
- Carrying a naloxone kit while traveling with the Jays, Schneider advocates for placing kits in all public spaces, comparing them to fire extinguishers or first-aid supplies.
- Experts hope a professional athlete sharing his story will help destigmatize opioid overdose prevention by encouraging the public to keep naloxone kits available in cars or bags for emergencies.
26 Articles
26 Articles
Davis Schneider's brother died of an overdose. Blue Jays say naloxone can save others
In 2020, Davis Schneider of the Toronto Blue Jays didn't know about naloxone, the drug that can reverse opioid overdoses and save lives if administered in time. He believes if someone had been with his brother at the time of his overdose, his life could have been saved.
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives
Star left fielder joins forces with Emergent to educate the public on the importance of being prepared with NARCAN® Nasal SpraySchneider shares his family’s story as part of Emergent’s Opioid Crisis Impact Map
Coverage Details
Bias Distribution
- 73% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium













